Group 1* | Group 2† | p Value | |
Number | 73 | 72 | |
At birth | |||
Male (n (%)) | 32 (44) | 38 (53) | 0.5 |
Birth weight (g) | 944 (800–1160) | 870 (760–1160) | 0.64 |
Post-conceptional age (weeks) | 28 (26–29) | 27.5 (26–29) | 0.83 |
Post-conceptional age <28 weeks | 34 (46) | 36 (50) | 0.7 |
(n (%)) | |||
At time zero | |||
Postnatal age (days) | 11 (7–18) | 10 (8–15) | 0.83 |
Body weight (g) | 938 (795–1140) | 870 (707–1170) | 0.95 |
Serum creatinine (μmol/l) | 70 (60–86) | 74 (55–104) | 0.34 |
Serum creatinine <90 μmol/l (n (%)) | 60 (82) | 50 (69) | 0.07 |
Treated patent ductus arteriosus (n (%)) | 11 (15) | 14( 19) | 0.48 |
Central venous line | 65 (89) | 63 (88) | 0.25 |
(n (%)) |
Data are median (Q25–Q75) or number (%).
*Group 1: 15 mg/kg/day or 25 mg/kg/day depending on whether serum creatinine was > or ⩽90 μmol/l.
†Group 2: 20 mg/kg/day or 30 mg/kg/day depending on whether serum creatinine was > or ⩽90 μmol/l.